Delivery Order SPE2DB20D3101-SPE2DB25FREE7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is a delivery order for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is for the delivery of Vivitrol 380 mg vials and diluents. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price delivery order. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, valued at $3,783.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price Delivery Order with a completion date of November 25, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has been awarded this contract as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,816.98 and a period of performance through November 21, 2024. The award is a delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award, valued at $3,003.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.06 firm-fixed-price delivery order is for the supply of 380 mg VIVITROL vials and diluents. The award has a completion date of May 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $7,775.05 and is for the delivery of VIVITROL 380 mg vials and diluents. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FREE7Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,003.51, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. This is a firm-fixed-price delivery order contract with a period of performance through March 12, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/11/25 |